Analystreport

Aldeyra Therapeutics, Inc (NASDAQ: ALDX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

Aldeyra Therapeutics, Inc.  (ALDX) 
Last aldeyra therapeutics, inc. earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aldeyra.com/investor-relations